You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Point-of-Care vs Laboratory INR Testing to Optimize Anticoagulation Management: WHO Is Correct?

  • Authors: Marcia L. Zucker PhD, FAACC; Lynn B. Oertel, ANP-BC, CACP; Nam K. Tran, PhD
  • CME / ABIM MOC / CE Released: 2/26/2019
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 2/26/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care physicians, hematology/oncology specialists, cardiologists, nurses, pharmacists, and other healthcare providers who care for patients requiring INR testing.

The goal of this activity is to improve providers' understanding of the key differences between point-of-care (POC) and laboratory international normalized ratio (INR) testing, as well as calibration requirements for prothrombin time (PT) INR devices.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key differences between POC and laboratory INR testing 
    • Recent updates on calibration requirements for POC INR test devices
  • Have greater competence related to
    • Interpreting POC INR test results to inform clinical decision making and optimize anticoagulation management


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Marcia L. Zucker, PhD, FAACC

    President
    ZIVD LLC
    Plaistow, New Hampshire

    Disclosures

    Disclosure: Marcia L. Zucker, PhD, FAACC, has disclosed the following relevant financial relationships:
    Served as a speaker or a member of a speakers bureau for: Abbott; Roche

Panelists

  • Lynn B. Oertel, ANP-BC, CACP

    Nursing Practice Specialist
    Massachusetts General Hospital
    Boston, Massachusetts

    Disclosures

    Disclosure: Lynn B. Oertel, ANP-BC, CACP, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Pfizer Inc.; Portola Pharmaceuticals, Inc.; Roche

  • Nam K. Tran, PhD

    Associate Professor
    Director
    Clinical Chemistry, Special Chemistry/Toxicology, and Point-of-Care Testing
    University of California, Davis, School of Medicine
    Sacramento, California

    Disclosures

    Disclosure: Nam K. Tran, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Roche

Editors

  • Joy P. Marko, MS, APN-C, CCMEP

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Joy P. Marko, MS, APN-C, CCMEP, has disclosed no relevant financial relationships.

  • Asha P. Gupta, PharmD, RPh

    Associate Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Asha P. Gupta, PharmD, RPh has disclosed no relevant financial relationships.

Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, CHCP, has disclosed no relevant financial relationships.

CME Reviewer

  • Esther Nyarko, PharmD

    Associate CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; Medtronic, Inc.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50  AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-19-049-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Point-of-Care vs Laboratory INR Testing to Optimize Anticoagulation Management: WHO Is Correct?

Authors: Marcia L. Zucker PhD, FAACC; Lynn B. Oertel, ANP-BC, CACP; Nam K. Tran, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC / CE Released: 2/26/2019

Valid for credit through: 2/26/2021

processing....

  • Print